MedArrive
PrivateLast Round
Series A
Extension
Apr 11, 2023
Total Funding Raised
$40.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MedArrive operates in Healthcare & Life Sciences and is based in Irving, Texas. Its latest recorded funding round was a Series A Extension round in April 2023.
MedArrive is a healthcare technology company that offers a care management platform designed to seamlessly extend care services into the home by connecting telemedicine with hands-on support from emergency medical supply professionals.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Logistics Software, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedArrive Comparables
Compare MedArrive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sprinter Health | 80% | |
| Axle Health | 79% | |
| Tomorrow Health | 77% |
For institutional investors. Book with your work email.
MedArrive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 11, 2023 | ||||
| Series A | Nov 17, 2021 | ||||
| Strategic | Aug 24, 2021 | ||||
| Seed | Dec 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MedArrive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Define Ventures | Series A, Seed |
| S32 | Series A |
| Cobalt Ventures | Series A Extension |
| 7wire Ventures | Series A |
| Kleiner Perkins | Series A, Seed |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 126% MoM, reaching 1.9K.
- Jun 18, 2026
Monthly visitors grew 208% MoM, from 276 to 850.
For institutional investors. Book with your work email.
MedArrive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedArrive's valuation, stock price, and market status.
Is MedArrive a public or private company?
MedArrive is a private company.
What is the current stock price of MedArrive?
MedArrive is a private company, so its shares have no public market price. Caplight tracks MedArrive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedArrive worth (valuation)?
Valuation information for MedArrive is not publicly available.
Can I buy MedArrive stock?
MedArrive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedArrive's last funding round?
MedArrive's most recent funding round was Series A Extension on April 11, 2023.
Who are the main investors in MedArrive?
Key investors in MedArrive include Define Ventures, S32, Cobalt Ventures, Kleiner Perkins.
Will MedArrive IPO soon?
No public IPO plans have been announced for MedArrive.
How can I track MedArrive secondary market activity?
Caplight tracks bids, offers, and trades in MedArrive's shares on secondary markets.